Modernization Roadmaps for Existing Buildings under Limited Energy Resources and Craftwork Capacities by Jan Richarz, Nico Fuchs, Dominik Hering, Dirk Müller

Get full text

Realization times of energetic modernization measures for buildings based on interviews with craftworkers by Jan Richarz, Nico Fuchs, Jacqueline Zurke, Jan Imberg, Tanja Datsko, Dominik Hering, Dirk Müller

Get full text

Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma—A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group by Michael Oertel, Priska Hölscher, Dominik Hering, Christopher Kittel, Michael Fuchs, Uwe Haverkamp, Peter Borchmann, Hans Theodor Eich

Get full text

Definition of an Normal Tissue Complication Probability Model for the Inner Ear in Definitive Radiochemotherapy of Nasopharynx Carcinoma by Leonie Peuker, Daniel Rolf, Michael Oertel, Alexander Peuker, Sergiu Scobioala, Dominik Hering, Claudia Rudack, Uwe Haverkamp, Hans Theodor Eich

Get full text

Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial by Michael Oertel, Dominik Hering, Christian Baues, Christopher Kittel, Michael Fuchs, Jan Kriz, Kai Kröger, Dirk Vordermark, Klaus Herfarth, Rita Engenhart-Cabillic, Peter Lukas, Uwe Haverkamp, Peter Borchmann, Hans Theodor Eich

Get full text

P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16 by Michael Oertel, Dominik Hering, Christopher Kittel, Nina Nacke, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Uwe Haverkamp, Andreas Engert, Hans Theodor Eich

Get full text

P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group by Michael Oertel, Dominik Hering, Nina Nacke, Christopher Kittel, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Andreas Engert, Uwe Haverkamp, Hans Theodor Eich

Get full text

P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial by Michael Oertel, Dominik Hering, Nina Nacke, Christopher Kittel, Kai Kröger, Jan Kriz, Michael Fuchs, Christian Baues, Dirk Vordermark, Rita Engenhart-Cabillic, Klaus Herfarth, Peter Lukas, Heinz Schmidberger, Simone Marnitz, Peter Borchmann, Andreas Engert, Uwe Haverkamp, Hans Theodor Eich

Get full text

Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era by Michael Oertel, MD, Dominik Hering, MSc, Nina Nacke, MSc, Christopher Kittel, MSc, Kai Kröger, MD, Jan Kriz, MD, Michael Fuchs, MD, Christian Baues, MD, Dirk Vordermark, MD, Rita Engenhart-Cabillic, MD, Klaus Herfarth, MD, Peter Lukas, MD, Heinz Schmidberger, MD, Simone Marnitz, MD, Peter Borchmann, MD, Andreas Engert, MD, Uwe Haverkamp, Hans Theodor Eich, MD

Get full text